GFRA3 (GDNF family receptor alpha 3) and KRT17 (keratin 17) had a different expression in normal and cancer tissues, with GFRA3 expression increasing in breast cancer and KRT17 expression decreasing in breast cancer, as shown in Table 6. This evidence concerns the gene KRT17 and breast carcinoma.